Launch of new cystic fibrosis test announced by industry leader.

摘要

Luminex Co. has announced the full commercial launch of its xTAG? Cystic Fibrosis 60 Kit v2, a new diagnostic test that can simultaneously screen a single blood sample for up to 60 cystic fibrosis (CF)-causing genetic mutations in a matter of hours.The test recently received 510 (k) clearance from the US FDA and covers more gene mutation coverage than any other test available. The kit can detect up to 60 CF transmembrane receptor gene mutations from a single patient blood sample.